Please login to the form below

Not currently logged in
Email:
Password:

FDA approves Teva's Alzheimer's drug

The US Food and Drug Administration has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept

The US Food and Drug Administration (FDA) has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept (donepezil).

Teva said that it has already begun shipping the product, in 5mg and 10mg tablets.

Aricept has been the market leader among drugs that alleviate symptoms of Alzheimer's disease, such as memory problems, confusion and aggression.

Annual sales of the drug in the US are believed to be $2.3 bn.

Meanwhile Teva has declined to comment on media reports that its president and chief executive Shlomo Yanai flew to India several days ago to discuss potential collaborations with Indian pharmaceutical companies.

2nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics